IP Library › Granted Patent US 6,124,316
Granted Patent Utility
US 6,124,316 · App. 09/306,825

Compounds which are specific antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools

Inventors: Daniel Bichon, Patrick Gueule, Didier Van Broeck, Xavier Emonds-Alt, Vincenzo Proietto
Patented Case View Patent ↗
Granted: Sep 26, 2000 Filed: May 7, 1999
Inventors
Daniel Bichon
Patrick Gueule
Didier Van Broeck
Xavier Emonds-Alt
Vincenzo Proietto
Assignee (at issue)
Sanofi

This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.

Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,124,316
App. No.
09/306,825
Filed
1999-05-07
Granted
2000-09-26
Kind
A